-
Hengrui medicine independently develops new anti-tumor drugs and is approved to carry out clinical trials
Time of Update: 2019-08-01
On July 31, Hengrui pharmaceutical announced that its company and its subsidiaries Shanghai Hengrui Pharmaceutical Co., Ltd and Suzhou shengdia biomedical Co., Ltd have recently received the notice of
-
Can't the medical representative get the fee? 20% drug generation is in transition
Time of Update: 2019-06-20
[pharmaceutical Station industry trends] in the pharmaceutical industry, the sales cost has been high Data shows that from 2016 to 2018, the sales expenses of 284 pharmaceutical companies in a share w
-
Scott Gottlieb, head of FDA, submits his resignation
Time of Update: 2019-03-07
On March 5, 2019, Scott Gottlieb, head of the U.S Food and Drug Administration (FDA), resigned, arteria.com learned According to the Washington Post, the first to report, Gottlieb will leave regulator
-
[quick news] on December 4, 2018, there was a shortage of talents in the field of artificial intelligence, and the annual salary of the doctoral students reached 500000 yuan
Time of Update: 2018-12-04
There is a shortage of talents in the field of artificial intelligence The annual salary of the new doctoral students reaches 500000 The continuous increase of the salary of the talents of artificial
-
Lilai and nextcure founded by Chen Liping to create the next generation of tumor immunotherapy
Time of Update: 2018-11-07
On November 5, Eli Lilly and company, a US pharmaceutical giant, and nextcure announced their cooperation in the discovery and development of new immune tumor drugs, aiming to make use of nextcure's p
-
Kangmei, Hengrui, Shanghai Pharmaceutical and other pharmaceutical enterprises have handed in their transcripts
Time of Update: 2018-10-31
After September, it's time for companies to disclose their performance statements As of October 29, according to incomplete statistics of local medical stations, 190 A-share listed pharmaceutical comp
-
New drugs for rare diseases accelerate the application of these pharmaceutical companies into China! Series one
Time of Update: 2018-05-24
Source: ihealth 2018-05-24 National Drug Administration and National Health Commission jointly released the announcement on optimizing the relevant matters of drug registration review and approval Amo
-
[hot spot] the personnel flow of the pharmaceutical circle is alarmed, and the pre market chapter of heavyweight innovative drugs is opened
Time of Update: 2018-05-03
On April 23, Pfizer China announced that after 15 years of service, Wu Xiaobin, President of Pfizer core medical Greater China and national manager of Pfizer China, left Pfizer to start a new business
-
FDA grants Sanofi a new inhibitor breakthrough therapy
Time of Update: 2017-09-11
[industry trends of China Pharmaceutical network] on September 9, Sanofi and regeneron pharmaceuticals announced that the US FDA granted its PD-1 inhibitor, cemiplimab (also known as regn2810), a brea
-
IPO of pharmaceutical industry is becoming more and more strict, and investment institutions need to take the initiative
Time of Update: 2017-07-26
[market analysis of chinapharma.com] in recent years, China's IPO audit has accelerated significantly However, as a pharmaceutical industry that has accounted for 10% of the meeting, the meeting rate
-
Outstanding achievements: nearly 70% of China's biopharmaceutical "troika" contribution
Time of Update: 2017-03-24
[China Pharmaceutical network enterprise news] on March 13, China biopharmaceutical released its 2016 annual performance announcement Among a number of pharmaceutical listed companies that have disclo
-
Cefalexin capsule orange peel book information (same as freehand medicine intelligent Edition
Time of Update: 2017-02-06
This orange peel book database is jointly produced by yaozhi.com and tonghuayi.com Drug name: Cefalexin capsule, specification: 0.125g/0.25g, the active ingredient of the original pragma arms LLC, the
-
The second issue of "search index report" of Yaozhi big data
Time of Update: 2016-04-27
Today is the second phase (March) of "search index report" of pharmaceutical intelligence big data Uncle formohol, editor in chief, will bring you the highlights of this phase: 1 Drugs with the highes
-
Under the great reward, there must be Yongfu AstraZeneca returning to the field of antibiotic research and development
Time of Update: 2015-09-21
Source: Biovalley 2015-09-21 September 21, 2015, the history of human medical development is almost the history of fighting against viruses and bacteria All kinds of major epidemics in history are alm
-
Daily News: Wen Qingwei, founder of the elite club of pharmaceutical intelligence
Time of Update: 2015-08-07
General manager of marketing center of Chongqing shenghuaxi Pharmaceutical Co., Ltd He has been deeply engaged in the pharmaceutical industry for more than 20 years He has successively worked in Chong
